Glycosphingolipids promote pro-atherogenic pathways in the pathogenesis of hyperglycemia-induced accelerated atherosclerosis
- 3 July 2018
- journal article
- research article
- Published by Springer Science and Business Media LLC in Metabolomics
- Vol. 14 (7), 92
- https://doi.org/10.1007/s11306-018-1392-2
Abstract
Three out of four people with diabetes will die of cardiovascular disease. However, the molecular mechanisms by which hyperglycemia promotes atherosclerosis, the major underlying cause of cardiovascular disease, are not clear.Funding Information
- Canadian Institutes of Health Research (MOP62910, MOP142248)
- Heart and Stroke Foundation of Canada (G-17-0017029)
This publication has 35 references indexed in Scilit:
- Metabolomics: the apogee of the omics trilogyNature Reviews Molecular Cell Biology, 2012
- The use of animal models in diabetes researchBritish Journal of Pharmacology, 2012
- Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific DeathThe New England Journal of Medicine, 2011
- Metabolomics and AtherosclerosisCurrent Atherosclerosis Reports, 2010
- Inhibition of Glycosphingolipid Synthesis Induces a Profound Reduction of Plasma Cholesterol and Inhibits Atherosclerosis Development in APOE*3 Leiden and Low-Density Lipoprotein Receptor−/− MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration studyThe Lancet, 2009
- Similarity of the Impact of Type 1 and Type 2 Diabetes on Cardiovascular Mortality in Middle-Aged SubjectsDiabetes Care, 2008
- Obesity and Diabetes in the Developing World — A Growing ChallengeThe New England Journal of Medicine, 2007
- Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993